Signaling Pathway
Fanastomig is a monoclonal antibody designed to target and inhibit both PDCD1 (Programmed cell death protein 1) and LAG3 (Lymphocyte activation gene-3). This dual-targeting approach enhances its potential for modulating immune responses, making it particularly relevant for research in immune checkpoint regulation and cancer immunotherapy.
重要通知：仅供研究使用。我们不向患者销售。
| Discription | Fanastomig is a monoclonal antibody designed to target and inhibit both PDCD1 (Programmed cell death protein 1) and LAG3 (Lymphocyte activation gene-3). This dual-targeting approach enhances its potential for modulating immune responses, making it particularly relevant for research in immune checkpoint regulation and cancer immunotherapy. |
||
|---|---|---|---|
| Targets |
|
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
